期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 37, 期 7, 页码 1836-1844出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/eji.200636689
关键词
glycolipids invariant; TCR NKT cell; rodents Th1/Th2
类别
We have demonstrated that analogues of alpha-mannosyl ceramide (alpha-ManCer) consisting of a series of immunosuppressive 2-aminoalcohol derivatives in place of sphingosine promote a greater immune response from mouse invariant V alpha 19-J alpha 26 (AV19-AJ33) TCR-bearing NKT (V alpha 19 NKT) cells than alpha-ManCer itself. To further characterize the immune responses of V alpha 19 NKT cells to the alpha-ManCer analogues, cytokine production by the cells was examined in detail. We found that certain alpha-ManCer derivatives individually induced either Th1- or Th2-dominant cytokine production in culture. The Th1- or Th2-biased immune responses of V alpha 19 NKT cells were dependent on MHC class I-like MR1, since they were induced by coculture with the MR1 transfectants previously loaded with the glycolipids and were inhibited in the presence of anti-MR1 antiserum. Presumably, the recognition of the alpha-mannosyl residue of the alpha-ManCer analogues by the invariant TCR is individually modulated, depending on the altered interaction with the groove of the antigen-presenting MR1. Priming of the V alpha 19 invariant TCR-transgenic mice in vivo with these glycolipid derivatives resulted in the induction of the Th1- or Th2-biased immune responses. Thus, these alpha-ManCer derivatives are likely to be useful in immunotherapy for either Th1 or Th2 excess autoimmune diseases, modulating the function of V alpha 19 NKT cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据